Peak6 Investments LLC Arbutus Biopharma Corp Put Options Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 12, 2023	SELL	$2.23 - $3.1 $396,494 - $551,180	-177,800 Reduced 88.77%	22,500 $68,000
Q4 2022 Feb 10, 2023	BUY	$1.91 - $2.85 $83,085 - $123,975	43,500 Added 27.74%	200,300 $467,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $294,784 - $451,584	156,800 New	156,800 $299,000
Q1 2022 May 13, 2022	SELL	$2.42 - $3.98 $96,800 - $159,200	-40,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.65 - $4.62 $106,000 - $184,800	40,000 New	40,000 $172,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $510M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.